Company
BioVie Inc
NASDAQ:BIVI
BioVie Inc. is a clinical-stage company developing innovative drug therapies for the treatment of neurological and neurodegenerative disorders (Alzheimer’s disease, Parkinson’s disease and long COVID) and advanced liver disease. In neurodegenerative disease, the company’s drug candidate bezisterim inhibits inflammatory activation of extracellular signal-regulated kinase and the transcription factor nuclear factor-κB, and the associated neuroinflammation and insulin resistance but not ERK and NFκB homeostatic functions (e.g., insulin signaling and neuron growth and survival).
58 stories · page 2 of 3
Archive
Nasdaq dragged down by Tesla, Apple as Bitcoin closes in on record high
The Nasdaq was down 0.4% at 16,207 points, the Dow Jones was 0.3% lower at 38,990 points and the S&P 500 was 0.1% lower at 5,130 points